What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Estudio internacional, de fase 2b, aleatorizado ydoble ciego para investigar la eficacia y la seguridad de redasemtide (S-005151) comparado con placebo enpacientes mayores de edad con ictus isquémico agudo que no son candidatos a tratamiento con activadortisular del plasminógeno o trombectomía Contact Protocol code: 2138P2231 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Molina Cateriano, Carlos Research group: Recerca en ictus Service: Neurologia Phase: Fase II Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos que evalúa los efectos del fármaco oral BI685509 (ajuste de dosis a un régimen de dosis fija) en hipertensión portal después de 8 semanas de tratamiento en pacientes con hipertensión clínicamente significativa (CSPH) en cirrosis descompensada después de su primer evento de descompensación, estabilizados CTP 5-7. Contact Protocol code: 1366-0055 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Pericàs Pulido, Juan Manuel Research group: Malalties hepàtiques Service: Sense classificar Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO EN FASE III, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE EFRUXIFERMIN EN SUJETOS CON ESTEATOHEPATITIS NO ALCOHÓLICA (EHNA) NO CIRRÓTICA Y FIBROSIS Contact Protocol code: AK-US-001-0105 EudraCT code: No aplica Pathology: Tumors Principal investigator: Pericàs Pulido, Juan Manuel Research group: Liver Diseases Service: Hepatologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A SINGLE-ARM, OPEN-LABEL, MULTI-CENTRE, PHASE IB STUDY EVALUATING THE SAFETY AND PRELIMINARY EFFICACY OF AUTO1 IN PAEDIATRIC PATIENTS WITH CD19-POSITIVE RELAPSED/ REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL) AND AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA (B NHL) Contact Protocol code: AUTO1-PY1 EudraCT code: No aplica Pathology: Tumors Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio fase 2/3, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos para evaluar la eficacia y la seguridad de belimumab ..administrado por vía subcutánea en adultos con enfermedad pulmonar intersticial asociada a esclerosis sistémica (SSc-ILD). Contact Protocol code: 218224 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Guillen Del Castillo, Alfredo Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, randomised, double-blind, parallel-group, event driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight related complications or risk factors for CVD Contact Protocol code: 1404-0040 EudraCT code: No aplica Pathology: Malalties endocrines, nutricionals i metabòliques Principal investigator: Simó Canonge, Rafael Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo Fase III aleatorizado, doble ciego, de grupos paralelos, controlado con placebo para evaluar la eficacia y seguridad de Tezepelumab en pacientes con Esofagitis Eosinofílica Contact Protocol code: D5244C00001 EudraCT code: 2022-001294-31 Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Guilarte Clavero, Mar Research group: Systemic Diseases Service: Internal Medicine Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH) Contact Protocol code: GB002-3101 EudraCT code: No aplica Pathology: Diseases of the respiratory system Principal investigator: López Meseguer, Manuel Research group: Pneumologia Service: Pneumologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. “ENSAYO EUROPEO DE PRUEBA DE CONCEPTO BASADO EN LA ESTRATIFICACIÓN TERAPÉUTICA SEGÚN LAS ANOMALÍAS MOLECULARES EN TUMORES EN RECAÍDA O REFRACTARIOS”. “EUROPEAN PROOF-OF-CONCEPT THERAPEUTIC STRATIFICATION TRIAL OF MOLECULAR ANOMALIES IN RELAPSED OR REFRACTORY TUMORS Contact Protocol code: CSET-2016/2369-ITCC-057 EudraCT code: 2016-000133-40 Pathology: Tumors Principal investigator: Hladun Alvaro, Raquel Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Phase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function Contact Protocol code: ARGX-117-2201 EudraCT code: 2022-503091-89-00 Principal investigator: Moreso Mateos, Francesc Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Títol Complet Servei de gestió integral d'administració de personal i aspectes associats, portal de l'empleat/da i registre horari per la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient SERVEIS DE GESTIÓ ADMINISTRACIÓ DE PERSONAL Codi 24967298 Data publicació Tue, 27 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT INFORME DE VALORACIÓ TÈCNICA ACORD ADJUDICACIÓ Year 2024 Títol Complet Serveis d’auditoria interna per evidenciar el nivell de compliment dels requisits del Sistema de Gestió de la Qualitat ISO 9001:2015, a càrrec de la Unitat de Qualitat de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR). Expedient AUDITORIA INTERNA Codi 24967297 Data publicació Wed, 28 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1.1 PCAP (word) ANNEX 1.2 PCAP (excel) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT ACCEPTACIÓ PROPOSTA D'ADJUDICACIÓ I REQUERIMENT ACORD D'ADJUDICACIÓ Year 2024 Títol Complet Development of a software for the management of candidatures an personnel selection, for the Human Resources Area of the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient RECRUITMENT SOFTWARE Codi 24967217 Data publicació Mon, 26 Feb 2024 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.PCAP PLIEGO DE CLÁUSULAS TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN Year 2024 Títol Complet Servicios de genotipado mediante Array GSAv4, destinado al Grupo de Psiquiatría, Salud Mental y Adicciones de la Fundació Hospital Universitari Vall Hebron – Institut de Recerca (VHIR). Expedient GENOTIPADO MEDIANTE ARRAY GSA (202228-30) Codi 24967064 Data publicació Thu, 22 Feb 2024 - 12:00 Documentos (enllaços) ANEXO 1.PCAP PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES PLIEGO DE CLÁUSULAS TÉCNICAS CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN INFORME DE VALORACIÓN TÉCNICA ADJUDICACIÓN PROVISIONAL Y REQUERIMIENTO ACUERDO DE ADJUDICACIÓN Year 2024 Títol Complet Contratación del servicio de secuenciación avanzada (con y sin análisis bioinformático) mediante las siguientes técnicas genómicas: Whole Genome Sequencing (WGS) y RNA sequencing (RNAseq) destinado al Grupo de Genética Del Cáncer Hereditario de la de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR), a cargo del proyecto PI22/01200 titulado “Secuenciación del genoma completo como primera prueba para mejorar el diagnóstico genético del cáncer de mama/ovario hereditario” subvencionado por el Instituto de Salud Carlos III (ISCIII) y cofinanciado por la Unión Europea. Expedient SECUENCIACIÓN DEL GENOMA (PI22/01200) Codi 24966638 Data publicació Mon, 12 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ ACLARATORIA ERROR ARITMETICO INFORME DE VALORACIÓ TÈCNICA ACORD ADJUDICACIÓ Professionals Tamara Gómez López Year 2024 Data d'inici Fri, 8 Mar 2024 - 12:00 Data de tancament Fri, 29 Mar 2024 - 12:00 Grup de recerca Liver Diseases Descripció Postdoc scientist - Advanced Chronic Liver Disease Laboratory_20240093 Codi 2024-93 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0093//2024_0093_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 8 Mar 2024 - 12:00 Data de tancament Fri, 29 Mar 2024 - 12:00 Grup de recerca Liver Diseases Descripció PhD candidate - Chronic Liver Disease Group -Liver Unit_ Codi 2024-94 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0094//2024_0094_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 7 Mar 2024 - 12:00 Data de tancament Thu, 21 Mar 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció Psychiatrist Researcher-Psychiatry, Mental Health and Addictions Research Group_20240090 Codi 2024-90 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0090//2024_0090_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 7 Mar 2024 - 12:00 Data de tancament Thu, 21 Mar 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció Nurse Psychiatrist-Mental Health and Addictions Group_20240091 Codi 2024-91 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0091//2024_0091_001.pdf Reclutant Inactiu Pagination First page « Previous page ‹ … Page 1441 Page 1442 Current page 1443 Page 1444 Page 1445 … Next page › Last page »
Year 2024 Títol Complet Servei de gestió integral d'administració de personal i aspectes associats, portal de l'empleat/da i registre horari per la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient SERVEIS DE GESTIÓ ADMINISTRACIÓ DE PERSONAL Codi 24967298 Data publicació Tue, 27 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT INFORME DE VALORACIÓ TÈCNICA ACORD ADJUDICACIÓ
Year 2024 Títol Complet Serveis d’auditoria interna per evidenciar el nivell de compliment dels requisits del Sistema de Gestió de la Qualitat ISO 9001:2015, a càrrec de la Unitat de Qualitat de la Fundació Hospital Universitari Vall d’Hebron - Institut de Recerca (VHIR). Expedient AUDITORIA INTERNA Codi 24967297 Data publicació Wed, 28 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1.1 PCAP (word) ANNEX 1.2 PCAP (excel) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT ACCEPTACIÓ PROPOSTA D'ADJUDICACIÓ I REQUERIMENT ACORD D'ADJUDICACIÓ
Year 2024 Títol Complet Development of a software for the management of candidatures an personnel selection, for the Human Resources Area of the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient RECRUITMENT SOFTWARE Codi 24967217 Data publicació Mon, 26 Feb 2024 - 12:00 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES ANEXO 1.PCAP PLIEGO DE CLÁUSULAS TÉCNICAS PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN
Year 2024 Títol Complet Servicios de genotipado mediante Array GSAv4, destinado al Grupo de Psiquiatría, Salud Mental y Adicciones de la Fundació Hospital Universitari Vall Hebron – Institut de Recerca (VHIR). Expedient GENOTIPADO MEDIANTE ARRAY GSA (202228-30) Codi 24967064 Data publicació Thu, 22 Feb 2024 - 12:00 Documentos (enllaços) ANEXO 1.PCAP PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES PLIEGO DE CLÁUSULAS TÉCNICAS CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN INFORME DE VALORACIÓN TÉCNICA ADJUDICACIÓN PROVISIONAL Y REQUERIMIENTO ACUERDO DE ADJUDICACIÓN
Year 2024 Títol Complet Contratación del servicio de secuenciación avanzada (con y sin análisis bioinformático) mediante las siguientes técnicas genómicas: Whole Genome Sequencing (WGS) y RNA sequencing (RNAseq) destinado al Grupo de Genética Del Cáncer Hereditario de la de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR), a cargo del proyecto PI22/01200 titulado “Secuenciación del genoma completo como primera prueba para mejorar el diagnóstico genético del cáncer de mama/ovario hereditario” subvencionado por el Instituto de Salud Carlos III (ISCIII) y cofinanciado por la Unión Europea. Expedient SECUENCIACIÓN DEL GENOMA (PI22/01200) Codi 24966638 Data publicació Mon, 12 Feb 2024 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC ACORD DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ APROVACIÓ DE L'EXPEDIENT RESOLUCIÓ DESIGNACIÓ MESA DE CONTRACTACIÓ ACLARATORIA ERROR ARITMETICO INFORME DE VALORACIÓ TÈCNICA ACORD ADJUDICACIÓ
Year 2024 Data d'inici Fri, 8 Mar 2024 - 12:00 Data de tancament Fri, 29 Mar 2024 - 12:00 Grup de recerca Liver Diseases Descripció Postdoc scientist - Advanced Chronic Liver Disease Laboratory_20240093 Codi 2024-93 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0093//2024_0093_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 8 Mar 2024 - 12:00 Data de tancament Fri, 29 Mar 2024 - 12:00 Grup de recerca Liver Diseases Descripció PhD candidate - Chronic Liver Disease Group -Liver Unit_ Codi 2024-94 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0094//2024_0094_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 7 Mar 2024 - 12:00 Data de tancament Thu, 21 Mar 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció Psychiatrist Researcher-Psychiatry, Mental Health and Addictions Research Group_20240090 Codi 2024-90 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0090//2024_0090_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 7 Mar 2024 - 12:00 Data de tancament Thu, 21 Mar 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció Nurse Psychiatrist-Mental Health and Addictions Group_20240091 Codi 2024-91 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0091//2024_0091_001.pdf Reclutant Inactiu
